MA49887A - Administration sous-cutanée d'un antagoniste du récepteur p2y12 - Google Patents

Administration sous-cutanée d'un antagoniste du récepteur p2y12

Info

Publication number
MA49887A
MA49887A MA049887A MA49887A MA49887A MA 49887 A MA49887 A MA 49887A MA 049887 A MA049887 A MA 049887A MA 49887 A MA49887 A MA 49887A MA 49887 A MA49887 A MA 49887A
Authority
MA
Morocco
Prior art keywords
receptor antagonist
subcutaneous administration
subcutaneous
administration
antagonist
Prior art date
Application number
MA049887A
Other languages
English (en)
Inventor
Martine Baumann
Markus Kramberg
Markus Rey
Markus Riederer
Sebastien Roux
Original Assignee
Idorsia Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Idorsia Pharmaceuticals Ltd filed Critical Idorsia Pharmaceuticals Ltd
Publication of MA49887A publication Critical patent/MA49887A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
MA049887A 2017-03-15 2018-03-14 Administration sous-cutanée d'un antagoniste du récepteur p2y12 MA49887A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP2017056175 2017-03-15

Publications (1)

Publication Number Publication Date
MA49887A true MA49887A (fr) 2020-06-24

Family

ID=61899166

Family Applications (1)

Application Number Title Priority Date Filing Date
MA049887A MA49887A (fr) 2017-03-15 2018-03-14 Administration sous-cutanée d'un antagoniste du récepteur p2y12

Country Status (18)

Country Link
US (1) US11179390B2 (fr)
EP (1) EP3595666A1 (fr)
JP (2) JP2020510043A (fr)
KR (1) KR102510832B1 (fr)
CN (1) CN110381947A (fr)
AU (1) AU2018234056B2 (fr)
BR (1) BR112019014567A2 (fr)
CA (1) CA3050831A1 (fr)
CL (1) CL2019002318A1 (fr)
EA (1) EA201992123A1 (fr)
IL (1) IL269286B2 (fr)
MA (1) MA49887A (fr)
MX (1) MX2019009559A (fr)
PH (1) PH12019502111A1 (fr)
SG (1) SG11201908128YA (fr)
TW (1) TWI765002B (fr)
UA (1) UA125531C2 (fr)
WO (1) WO2018167139A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109715639B (zh) 2016-09-22 2022-04-19 爱杜西亚药品有限公司 结晶形式
AU2021309018A1 (en) 2020-07-15 2023-03-16 Idorsia Pharmaceuticals Ltd Aqueous pharmaceutical composition comprising a P2Y12 receptor antagonist
IL309948A (en) 2021-07-13 2024-03-01 Idorsia Pharmaceuticals Ltd A process for the synthesis of 4-((R)-2-{[6-((S)-3-methoxy-pyrrolidin-1-yl)-2-phenyl-pyrimidin-4-carbonyl]-amino}-3-phosphono- Propionyl)-piperazine-1-carboxylic acid butyl ester
WO2023174810A1 (fr) 2022-03-14 2023-09-21 Idorsia Pharmaceuticals Ltd Procédé de synthèse d'acide ( r)-2-(( tert-butoxycarbonyl)amino)-3-(diéthoxyphosphoryl)propanoïque ou de dérivés de phosphonate de celui-ci

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3870035A (en) 1970-07-17 1975-03-11 Survival Technology Method and apparatus for self-administering pre-hospital phase treatment of coronary prone individuals in the early minutes or hours after the onset of heart attack symptoms
US4004577A (en) 1972-12-04 1977-01-25 Survival Technology, Inc. Method of treating heart attack patients prior to the establishment of qualified direct contact personal care
JPS5373586A (en) 1976-12-09 1978-06-30 Mitsubishi Chem Ind Ltd New penicillin derivatives
US5078680A (en) 1984-08-08 1992-01-07 Survival Technology, Inc. Automatic injector for emergency treatment
US4795433A (en) 1985-05-20 1989-01-03 Survival Technology, Inc. Automatic injector for emergency treatment
US4658830A (en) 1984-08-08 1987-04-21 Survival Technology, Inc. Method and apparatus for initiating reperfusion treatment by an unattended individual undergoing heart attack symptoms
GR861289B (en) 1985-05-20 1986-09-16 Survival Technology Injection method and apparatus with electrical blood absorbing stimulation
CA2020437A1 (fr) 1989-07-05 1991-01-06 Yoshihide Fuse Derive de cinnamamide
AU5414000A (en) 1999-06-14 2001-01-02 Eli Lilly And Company Compounds
US6861424B2 (en) 2001-06-06 2005-03-01 Schering Aktiengesellschaft Platelet adenosine diphosphate receptor antagonists
DE60333866D1 (de) 2002-12-11 2010-09-30 Bayer Schering Pharma Ag 2-aminocarbonlyl-chinolin-verbindungen als adenosin diphosphat plättchenrezeptor antagonisten
WO2004092189A1 (fr) 2003-04-09 2004-10-28 Wyeth Derives d'acide 2-(8,9-dioxo-2,6-diazabicyclo(5.2.0)non-1(7)-en-2-yl)alkyl phosphonique et leur utilisation comme antagonistes du recepteur n-methyl-d-aspartate (nmda)
AU2003249865A1 (en) * 2003-06-24 2005-01-21 Actelion Pharmaceuticals Ltd Pyrazolidinedione derivatives and their use as platelet aggregation inhibitors
TW200640877A (en) 2005-04-28 2006-12-01 Actelion Pharmaceuticals Ltd Pyrimidine derivatives
AR057836A1 (es) 2005-10-21 2007-12-19 Actelion Pharmaceuticals Ltd Piperizinas como agentes contra la malaria
AR063258A1 (es) 2006-10-13 2009-01-14 Actelion Pharmaceuticals Ltd Derivados de 2-aminocarbonil-piridina, una composicion farmaceutica que los contiene y su uso en la preparacion de un medicamento para el tratamiento de trastornos vasculares oclusivos.
AR063518A1 (es) 2006-10-25 2009-01-28 Actelion Pharmaceuticals Ltd Derivados 2-fenil-6-aminocarbonil-pirimidina; composicion farmaceutica; y su uso para tratar y/o prevenir enfermedades vasculares perifericas viscerales, hepaticas y renales, enfermedades cardiovasculares y enfermedades cerebrovasculares asociados con la agregacion de plaquetas, incluyendo trombosis
JP4785881B2 (ja) 2007-02-27 2011-10-05 大塚製薬株式会社 医薬
MX2009011089A (es) 2007-04-23 2009-10-30 Sanofi Aventis Derivados de quinolina-carboxamida en calidad de antagonistas de p2y12.
JP2010526101A (ja) 2007-05-02 2010-07-29 ポートラ ファーマシューティカルズ， インコーポレイテッド 直接作用型および可逆的ｐ２ｙ１２阻害剤の静脈および経口投与
RU2483072C2 (ru) 2007-11-29 2013-05-27 Актелион Фармасьютиклз Лтд Производные фосфоновой кислоты и их применение в качестве антагонистов рецептора p2y12
EP2238128B1 (fr) 2007-12-26 2012-08-22 Sanofi Pyrazole-carboxamides hétérocycliques utilisés en tant qu'antagonistes du récepteur p2y12
EP2238127B1 (fr) 2007-12-26 2012-08-15 Sanofi Dérivés de pyrazole-carboxamide utiles en tant qu'antagonistes de p2y12
AR071653A1 (es) 2008-04-11 2010-07-07 Actelion Pharmaceuticals Ltd Derivados 2-fenil-4-ciclopropil-pirimidina
AR071652A1 (es) 2008-04-11 2010-07-07 Actelion Pharmaceuticals Ltd Derivados 2- fenil-piridina substituidos
SG175075A1 (en) 2009-04-08 2011-11-28 Actelion Pharmaceuticals Ltd 6-(3-aza-bicyclo[3.1.0]hex-3-yl)-2-phenyl-pyrimidines as adp receptor antagonists
ES2469847T3 (es) 2009-04-22 2014-06-20 Actelion Pharmaceuticals Ltd. Derivados de tiazol y su uso como antagonistas del receptor P2Y12
WO2011137459A1 (fr) * 2010-04-30 2011-11-03 Portola Pharmaceuticals, Inc. Formes galéniques de l'élinogrel et leurs méthodes d'administration injectables
EP2585161A1 (fr) 2010-06-23 2013-05-01 Stefan Kralev Dispositif médical permettant une auto-administration par des patients présentant des risques d'accidents coronariens aigus
CN109715639B (zh) 2016-09-22 2022-04-19 爱杜西亚药品有限公司 结晶形式

Also Published As

Publication number Publication date
JP2020510043A (ja) 2020-04-02
US20200129510A1 (en) 2020-04-30
SG11201908128YA (en) 2019-10-30
CL2019002318A1 (es) 2020-01-10
TWI765002B (zh) 2022-05-21
AU2018234056B2 (en) 2023-05-25
KR20190124297A (ko) 2019-11-04
EA201992123A1 (ru) 2020-02-25
EP3595666A1 (fr) 2020-01-22
CN110381947A (zh) 2019-10-25
WO2018167139A1 (fr) 2018-09-20
UA125531C2 (uk) 2022-04-13
KR102510832B1 (ko) 2023-03-15
US11179390B2 (en) 2021-11-23
IL269286B2 (en) 2023-08-01
BR112019014567A2 (pt) 2020-02-18
JP2023052576A (ja) 2023-04-11
MX2019009559A (es) 2019-10-15
TW201840323A (zh) 2018-11-16
AU2018234056A1 (en) 2019-10-31
CA3050831A1 (fr) 2018-09-20
IL269286A (en) 2019-11-28
IL269286B1 (en) 2023-04-01
PH12019502111A1 (en) 2020-03-16

Similar Documents

Publication Publication Date Title
MA49887A (fr) Administration sous-cutanée d'un antagoniste du récepteur p2y12
MA41117A (fr) Imagerie d'un corps
DK3331886T3 (da) Dopamin-d3-receptorantagonister med en bicyclo-del
IL271777A (en) Preparations for intravenous administration of medical substances
EA201890156A1 (ru) Антагонисты рецептора cgrp
MA42689A (fr) Micropropagation d'un dattier t-r
MA42698A (fr) Micropropagation d'un dattier hdt
IL271694A (en) Novel uses of a pure 6HT–5 receptor antagonist
FR3027173B1 (fr) Architecture d'un reseau de telecommunication
MA54761A (fr) Administration d'un inhibiteur de signalisation de trans-signalisation par il-6 sélectif
DK3512518T3 (da) Buprenophinformuleringer med langvarig frigivelse
FR3030165B1 (fr) Synchronisation d'un reseau cpl
HK1247105A1 (zh) Mu類鴉片受體拮抗劑與類鴉片藥劑的組合劑型
DK3681564T3 (da) Lægemiddeladministrationsanordning
IT201700072079A1 (it) Struttura di un'attrezzatura di stampaggio ad iniezione
FR3045443B1 (fr) Fond de moule pourvu d'un insert mobile central
UA38991S (uk) Інтерфейс сайта «аutolinе»
UA34460S (uk) Брошка «зустріч багатства»
UA34471S (uk) Перстень «зустріч розсудливості»
UA35842S (uk) Конструкція «полконайзер» для створення стелажів
UA37867S (uk) Каблучка «дві клюшки»
UA37687S (uk) Каблучка «три клюшки»
IT201700116428U1 (it) Uncinetto bobo'
UA34472S (uk) Перстень «зустріч благородності»
UA34470S (uk) Перстень «зустріч благочестя»